Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
McKesson Corporation
Haemonetics Corporation
Henry Schein Inc
Quanterix Corporation Common Stock
Cardinal Health, Inc.
HealthEquity, Inc
Medpace Holdings, Inc. Common Stock
ResMed Inc.
DexCom, Inc.
The chart shows the growth of an initial investment of $10,000 in Align Technology Inc, comparing it to the performance of the S&P 500 index.
All prices have been adjusted for splits and dividends.
Align Technology Inc (ALGN) has returned 8.17% so far this year and 14.88% over the past 12 months. Looking at the last ten years, ALGN has achieved an annualized return of 8.81%, underperforming the Benchmark (SPY), which averaged 12.23% per year.
The table below presents the monthly returns of Align Technology Inc (ALGN) with color gradation from worst to best to easily spot seasonal factors.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 3.37% | 16.75% | -7.13% | -1.16% | ||||||||
| 2025 | 3.47% | -12.56% | -15.78% | 10.34% | -4.77% | 5.25% | -31.40% | 10.05% | -9.82% | 9.16% | 6.99% | 7.62% |
| 2024 | -1.36% | -0.19% | 8.81% | -13.65% | -8.80% | -6.14% | -4.04% | 2.98% | 8.58% | -19.55% | 13.65% | -9.82% |
| 2023 | 25.19% | 14.51% | 8.66% | -2.40% | -13.00% | 24.67% | 7.75% | -1.21% | -18.61% | -39.07% | 16.36% | 28.46% |
| 2022 | -24.58% | 3.50% | -14.30% | -34.02% | -5.07% | -15.80% | 18.54% | -12.44% | -13.33% | -7.10% | -0.45% | 6.74% |
| 2021 | -4.41% | 5.03% | -4.59% | 9.02% | -1.50% | 3.13% | 14.19% | 1.29% | -6.69% | -7.09% | -3.16% | 5.50% |
| 2020 | -8.57% | -15.20% | -20.54% | 30.93% | 18.04% | 10.96% | 6.48% | 0.33% | 10.19% | 27.71% | 11.38% | 9.63% |
| 2019 | 21.25% | 4.39% | 8.84% | 12.96% | -12.58% | -3.24% | -25.50% | -12.43% | -0.72% | 39.22% | 9.06% | 0.90% |
| 2018 | 17.69% | 0.36% | -1.52% | -0.46% | 33.20% | 2.69% | 6.49% | 8.37% | 1.18% | -43.77% | 3.43% | -10.65% |
| 2017 | -4.97% | 5.94% | 10.54% | 16.93% | 7.25% | 2.57% | 10.70% | 5.57% | 5.35% | 27.69% | 7.36% | -14.33% |
| 2016 | -0.52% | 8.64% | 2.07% | 10.42% | 3.81% | 0.59% | -6.65% | 8.37% | 3.23% |
The charts below present risk-adjusted performance metrics for Align Technology Inc (ALGN) and compare them to a Benchmark (SPY). These indicators evaluate an investment's returns against its associated risks.
The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.
These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns.
The chart below shows the rolling Sharpe ratio of ALGN compared to the benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.
The current Align Technology Inc volatility is 2.82%, representing the standart deviation of percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
The Drawdowns chart displays portfolio losses from any high point along the way. It shows the maximum percentage drop from a peak to a trough over a specified period, indicating the risk of significant losses.
Although chart shows positive values, it represents the percentage drop from the peak, so a value of 10% means the portfolio has dropped 10% from its highest point.
The income statement provides a summary of a company's revenues, expenses, and profits over a specific period. It shows how much money the company earned (revenues) and how much it spent (expenses), leading to the net income or profit. This statement is crucial for understanding a company's financial performance and profitability.
| 2025 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities And Equity (USD) | 6.23B | 6.08B | 5.95B | 5.94B | 4.83B | 2.50B | 2.05B | 1.78B | 1.40B | 1.16B | 988.00M | 832.15M | 756.31M | 649.26M |
| Equity Attributable To Parent (USD) | 4.05B | 3.63B | 3.60B | 3.62B | 3.23B | 1.35B | 1.25B | 1.15B | 995.39M | 847.93M | 752.77M | 633.97M | 581.32M | 490.78M |
| Equity Attributable To Noncontrolling Interest (USD) | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Equity (USD) | 4.05B | 3.63B | 3.60B | 3.62B | 3.23B | 1.35B | 1.25B | 1.15B | 995.39M | 847.93M | 752.77M | 633.97M | 581.32M | 490.78M |
| Noncurrent Liabilities (USD) | 264.53M | 386.78M | 420.70M | 395.33M | 270.22M | 183.56M | 107.49M | 129.67M | 46.43M | 39.04M | 33.42M | 22.84M | 19.22M | 10.37M |
| Other Current Liabilities (USD) | 1.57B | 1.73B | 1.65B | 1.47B | 1.01B | 721.23M | 500.71M | 358.04M | 246.53M | 181.89M | 133.95M | 114.59M | 96.60M | 87.03M |
| Wages (USD) | 226.15M | 220.86M | 149.51M | 288.36M | 170.11M | 162.49M | 127.11M | 103.00M | 79.21M | 55.43M | 44.61M | 43.03M | 39.62M | 41.83M |
| Accounts Payable (USD) | 121.45M | 113.13M | 127.87M | 163.89M | 142.13M | 87.25M | 64.26M | 36.78M | 28.60M | 34.35M | 23.25M | 17.72M | 19.55M | 19.27M |
| Current Liabilities (USD) | 1.92B | 2.07B | 1.93B | 1.92B | 1.33B | 970.97M | 692.07M | 497.82M | 354.34M | 271.67M | 201.81M | 175.34M | 155.77M | 148.12M |
| Liabilities (USD) | 2.18B | 2.45B | 2.35B | 2.32B | 1.60B | 1.15B | 799.57M | 627.49M | 400.76M | 310.71M | 235.23M | 198.18M | 175.00M | 158.48M |
| Other Non-current Assets (USD) | 2.39B | 2.26B | 2.20B | 2.26B | 2.12B | 235.55M | 228.65M | 272.06M | 268.01M | 290.15M | 240.71M | 187.99M | 145.55M | 160.46M |
| Intangible Assets (USD) | 93.93M | 82.12M | 95.72M | 109.71M | 130.07M | - | - | - | - | - | - | 23.74M | 45.78M | 50.02M |
| Fixed Assets (USD) | 1.13B | 1.29B | 1.23B | 1.08B | 734.72M | 631.73M | 521.33M | 348.79M | 175.17M | 136.47M | 90.13M | 75.74M | 79.19M | 53.97M |
| Noncurrent Assets (USD) | 3.62B | 3.64B | 3.52B | 3.45B | 2.98B | 867.28M | 749.98M | 620.85M | 443.17M | 426.62M | 330.84M | 287.47M | 270.52M | 264.45M |
| Other Current Assets (USD) | 2.33B | 2.10B | 2.02B | 2.19B | 1.71B | 1.52B | 1.25B | 1.13B | 925.85M | 712.55M | 641.23M | 530.71M | 470.67M | 375.41M |
| Prepaid Expenses (USD) | 62.48M | 52.49M | 69.12M | 70.22M | - | - | - | - | - | - | - | - | - | - |
| Inventory (USD) | 226.34M | 296.90M | 338.75M | 230.23M | 139.24M | 112.05M | 55.64M | 31.69M | 27.13M | 19.47M | 15.93M | 13.97M | 15.12M | 9.40M |
| Current Assets (USD) | 2.62B | 2.45B | 2.42B | 2.49B | 1.85B | 1.63B | 1.30B | 1.16B | 952.98M | 732.01M | 657.16M | 544.68M | 485.79M | 384.82M |
| Assets (USD) | 6.23B | 6.08B | 5.95B | 5.94B | 4.83B | 2.50B | 2.05B | 1.78B | 1.40B | 1.16B | 988.00M | 832.15M | 756.31M | 649.26M |
Activist investor Elliott Investment Management has taken a large stake in Align Technology (ALGN), positioning itself to push for strategic changes to boost shareholder value. The move comes as Align struggles with weakened demand post-pandemic, though Q4 2025 showed record Invisalign volumes. Barclays upgraded the stock to Overweight with a $200 price target, citing recovery potential as geopolitical concerns stabilize and the stock trades below historical valuation multiples.
The global clear aligners market is valued at $11.23 billion in 2026 and is expected to grow to $99.44 billion by 2034, expanding at a 31.34% CAGR. North America leads the market while Asia Pacific shows the fastest growth. Adults dominate by age segment, polyurethane leads by material type, and online distribution channels are expected to grow fastest. Key drivers include rising demand for aesthetic orthodontic solutions, technological advancements in 3D imaging and AI, and expanding access through digital platforms.
The global invisible orthodontics market is projected to grow from USD 9.91 billion in 2025 to USD 96.27 billion by 2034, expanding at a CAGR of 28.54%. Clear aligners dominate the product segment, with North America leading regionally and Asia-Pacific showing significant growth potential. Adults currently represent the largest age segment, while the teens segment is expected to grow rapidly. Key drivers include rising dental misalignment cases, technological advancements in 3D printing, and increased consumer awareness of aesthetic dental solutions.
Align Technology reported record Invisalign case submissions in Q4 with 87.7 thousand doctors submitting cases. Revenue beat expectations at $1.048 billion (+5.3% YoY) and adjusted EPS of $3.29 surpassed consensus of $2.97. The company projects 3-4% revenue growth for fiscal 2026 with improving margins, sending shares up 10.43% in premarket trading.
The article highlights three under-the-radar tech stocks with potential upside: Align Technology, Marvell Technology, and EPAM Systems. These companies offer unique opportunities beyond the Magnificent Seven tech stocks, with strong fundamentals and growth potential in their respective niches.
Align Technology reported Q3 earnings beating analyst expectations, with sales growing less than 2% year-over-year. Despite a stock price increase, the company's earnings and free cash flow are declining, suggesting potential challenges.
Law firm investigating potential securities law violations by Align Technology after significant stock price drop following missed financial expectations in Q2 2025.
Pomerantz Law Firm is investigating potential securities fraud at Align Technology after the company missed revenue estimates, lowered guidance, and experienced a significant stock price drop of 36.63%.
Pomerantz Law Firm is investigating potential securities fraud at Align Technology after the company missed revenue estimates and lowered financial guidance, causing a significant stock price drop.
Law firm investigating potential securities law violations by Align Technology after significant stock price drop following missed financial expectations in Q2 2025.